Fiscal year 2025 executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.
Each company listed discloses RDNT in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named RDNT in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Howard Berger | $3,000,000 | $0 | $8,999,966 | $0 | $0 | $0 | $87,968 | $12,087,934 |
| President and Chief Executive Officer | ||||||||
| Stephen Forthuber | 800,000 | 400,000 | 1,999,952 | 0 | 0 | 0 | 54,494 | 3,254,446 |
| President and Chief Operating Officer - Eastern Operations | ||||||||
| Norman Hames | 800,000 | 400,000 | 1,999,952 | 0 | 0 | 0 | 38,104 | 3,238,056 |
| President and Chief Operating Officer - Western Operations | ||||||||
| Mital Patel | 750,000 | 375,000 | 1,874,960 | 0 | 0 | 0 | 55,594 | 3,055,554 |
| Executive Vice President of Financial Planning and Analysis and Chief Administrative Officer | ||||||||
| Mark Stolper | 700,000 | 350,000 | 1,749,967 | 0 | 0 | 0 | 33,522 | 2,833,489 |
| Executive Vice President and Chief Financial Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Howard Berger | $12,087,934 | — | — | — |
| Stephen Forthuber | 3,254,446 | — | — | — |
| Norman Hames | 3,238,056 | — | — | — |
| Mital Patel | 3,055,554 | — | — | — |
| Mark Stolper | 2,833,489 | — | — | — |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Howard Berger | Director | 2026-05-05 | A | 25,992 | $19 | $484,491 | Common | Form 4 ↗ |
| Howard Berger | Director | 2026-05-05 | D | 25,992 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| David L. Swartz | Director | 2026-06-02 | A | 2,946 | 0 | 0 | Common | Form 4 ↗ |
| Lawrence L. Levitt | Director | 2026-06-02 | A | 2,946 | 0 | 0 | Common | Form 4 ↗ |
| Laura P. Jacobs | Director | 2026-06-02 | A | 2,946 | 0 | 0 | Common | Form 4 ↗ |
| Gregory E. Spurlock | Director | 2026-06-02 | A | 2,946 | 0 | 0 | Common | Form 4 ↗ |
| Stephen Forthuber | Pres & CEO-Eastern Operations | 2026-06-15 | D | 24,214 | 58 | 1,399,327 | Common | Form 4 ↗ |
| Stephen Forthuber | Pres & CEO-Eastern Operations | 2026-06-15 | D | 19,853 | 59 | 1,163,584 | Common | Form 4 ↗ |
| Cornelis Wesdorp | Pres & CEO, Digital Health | 2026-06-16 | D | 4,750 | 58 | 276,023 | Common | Form 4 ↗ |
| Howard Berger | Director | 2026-06-16 | D | 90 | 0 | 0 | Common | Form 4 ↗ |
| David L. Swartz | Director | 2026-06-18 | D | 2,699 | 54 | 145,449 | Common | Form 4 ↗ |
Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Norman Hames | PSU | — | — | — | 27,681 | — | $1,999,952 |
| Stephen Forthuber | PSU | — | — | — | 27,681 | — | 1,999,952 |
| Mark Stolper | PSU | — | — | — | 24,221 | — | 1,749,967 |
| Howard Berger | PSU | — | — | — | 124,567 | — | 8,999,966 |
| Mital Patel | PSU | — | — | — | 25,951 | — | 1,874,960 |
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| Norman Hames | $0 | $1,999,952 | $0 | 100.0% |
| Stephen Forthuber | 0 | 1,999,952 | 0 | 100.0% |
| Mark Stolper | 0 | 1,749,967 | 0 | 100.0% |
| Howard Berger | 0 | 8,999,966 | 0 | 100.0% |
| Mital Patel | 0 | 1,874,960 | 0 | 100.0% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Mital Patel | RSU | 7,711 | — | $550,180 |
| Norman Hames | Option | 22,526 | 18.64 | — |
| Mital Patel | RSU | 5,318 | — | 379,439 |
| Stephen Forthuber | Option | 2,004 | 29.44 | — |
| Mark Stolper | RSU | 4,853 | — | 346,262 |
| Howard Berger | Option | 51,984 | 18.64 | — |
| Howard Berger | RSU | 99,653 | — | 7,110,242 |
| Mital Patel | Option | 19,927 | 18.64 | — |
| Stephen Forthuber | RSU | 6,012 | — | 428,956 |
| Howard Berger | RSU | 20,118 | — | 1,435,419 |
| Mark Stolper | Option | 1,618 | 29.44 | — |
| Stephen Forthuber | RSU | 22,145 | — | 1,580,046 |
| Mark Stolper | RSU | 7,036 | — | 502,019 |
| Mark Stolper | Option | 18,184 | 18.64 | — |
| Norman Hames | RSU | 22,145 | — | 1,580,046 |
| Norman Hames | RSU | 8,717 | — | 621,958 |
| Norman Hames | RSU | 6,012 | — | 428,956 |
| Mital Patel | Option | 1,773 | 29.44 | — |
| Stephen Forthuber | Option | 22,526 | 18.64 | — |
| Mark Stolper | RSU | 18,311 | — | 1,306,490 |
| Howard Berger | RSU | 18,498 | — | 1,319,832 |
| Stephen Forthuber | RSU | 8,717 | — | 621,958 |
| Norman Hames | Option | 2,004 | 29.44 | — |
| Mital Patel | RSU | 20,761 | — | 1,481,297 |
Our Management Team is Integral to our Success. At the core of our compensation philosophy is the guiding belief that our management team is an integral component to RadNet's continued success. Compensation Decisions Should Promote the Interests of Stockholders. Compensation should create incentives for management to achieve strong short-term (annual) performance in a manner that supports and ensures our long-term success and profitability.
| CEO STI target (% of salary) | — |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Pearl Meyer |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | True |
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-06-02 | 61,158,497 | 3,892,047 | 82,662 | 93.9% | Passed |
| 2025 | 2025-06-10 | 50,822,611 | 10,417,523 | 80,015 | 82.88% | Passed |
| 2024 | 2024-06-12 | 53,924,684 | 6,798,266 | 120,033 | 88.63% | Passed |
| 2023 | 2023-06-07 | 38,588,086 | 5,318,535 | 97,188 | 87.69% | Passed |
| 2022 | 2022-06-08 | 41,279,176 | 1,987,913 | 54,620 | 95.41% | Passed |
| 2021 | 2021-06-10 | 38,083,103 | 1,694,793 | 16,853 | 95.74% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.
| Meeting year | Meeting date | Approval — company's computation |
|---|---|---|
| 2026 | 2026-06-02 | 93.9%a |
| 2025 | 2025-06-10 | 82.88%b |
| 2024 | 2024-06-12 | 88.63%c |
a. Approved under the standard stated in the filing — “Abstentions will have the effect of a vote of "AGAINST" for a director in Proposal No.”.
b. Approved under the standard stated in the filing — “Abstentions will have the effect of a vote of "AGAINST" for a director in Proposal No.”.
c. Approved under the standard stated in the filing — “Abstentions will have the effect of a vote of "AGAINST" for a director in Proposal No.”.
Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
| Ratio (CEO : median employee) | 263 : 1 |
|---|---|
| CEO total compensation | $12,087,934 |
| Median employee compensation | $45,880 |
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| David L. SwartzIndependent · Lead Independent Director · Audit (Chair) · Compensation · Nominating/Governance | $148,500 | $160,024 | $0 | $0 | $0 | $308,524 |
| Lawrence L. LevittIndependent · Audit · Compensation (Chair) · Nominating/Governance | 113,500 | 160,024 | 0 | 0 | 0 | 273,524 |
| Laura P. JacobsIndependent · Audit · Compensation · Nominating/Governance (Chair) | 108,500 | 160,024 | 0 | 0 | 0 | 268,524 |
| Gregory E. SpurlockIndependent · Compensation · Nominating/Governance | 91,000 | 160,024 | 0 | 0 | 0 | 251,024 |
| A. Gregory Sorensen, M.DEmployee director | 0 | 0 | 0 | — | 0 | 0 |
| Howard G. Berger, M.DEmployee director · Board Chair | 0 | 0 | 0 | — | 0 | 0 |
| Annual cash retainer | $85,000 |
|---|---|
| Annual equity retainer | $160,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 20,000 / 10,000 |
| Stock ownership guideline | — |
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $461,500 |
| Equity awards (grant-date value) | $640,096 |
| All other compensation | $0 |
| Total cost of the board | $1,101,596 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
Of the companies RadNet names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.
Reciprocity shown where the peer's own current proxy has been read — each mark is cited in the register to that peer's filing. A dash means the peer's current proxy was read and names no reciprocal group including RadNet.
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Astrana Health, Inc. | 2025 | Brandon Sim | $850,000 | $11,999,980 | $0 | $2,059,125 | $14,930,231 |
| 2 | The Ensign Group, Inc. | 2025 | Barry Port | 549,264 | 2,912,355 | 0 | 10,317,247 | 13,804,700 |
| 3 | Chemed Corporation | 2025 | Kevin McNamara | 1,862,837 | 2,883,553 | 5,036,021 | 1,486,976 | 12,904,720 |
| 4 | RadNet | 2025 | Howard Berger | 3,000,000 | 8,999,966 | 0 | 0 | 12,087,934 |
| 5 | Encompass Health Corporation | 2025 | Mark Tarr | 1,100,000 | 5,285,381 | 1,165,376 | 2,581,525 | 10,297,258 |
| 6 | AdaptHealth Corp | 2025 | Suzanne Foster | 1,000,000 | 7,530,880 | 0 | 1,394,694 | 10,256,240 |
| 7 | Option Care Health, Inc. | 2025 | John Rademacher | 1,000,000 | 6,500,050 | 0 | 1,665,000 | 9,266,330 |
| 8 | Acadia Healthcare Company, Inc. | 2025 | Christopher Hunter | 1,061,000 | 5,712,012 | 0 | 1,135,270 | 7,909,463 |
| 9 | Surgery Partners, Inc. | 2025 | J. Eric Evans | 1,050,000 | 5,000,000 | 0 | 0 | 6,083,862 |
| 10 | Aveanna Healthcare Holdings Inc. | 2025 | Jeffrey Shaner | 750,000 | 2,603,993 | 0 | 1,500,000 | 4,864,165 |
| 11 | Select Medical Holdings Corporation | 2025 | Thomas Mullin | 618,000 | 1,425,000 | 0 | 939,360 | 3,042,527 |
| 12 | Pediatrix Medical Group, Inc. | 2025 | James Swift | 54,167 | 730,720 | 0 | 68,981 | 2,775,881 |
| — | PACS Group, Inc. | — | — | — | — | — | — | not in coverage universe |
| — | Amedisys, Inc. | — | — | — | — | — | — | not in coverage universe |
| — | U.S. Physical Therapy, Inc. | — | — | — | — | — | — | not in coverage universe |
| — | Concentra Group Holdings Parent, Inc. | — | — | — | — | — | — | not in coverage universe |
| — | Addus HomeCare Corporation | — | — | — | — | — | — | not in coverage universe |
Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| RadNet | not disclosed | RSU 100 | No | Pearl Meyer |
| Acadia Healthcare Company, Inc. | 85.6% | PSU 50 · RSU 50 | No | Willis Towers Watson |
| AdaptHealth Corp | 116.22% | PSU 50 · RSU 50 | Yes — Relative TSR | ClearBridge |
| Addus HomeCare Corporation | not disclosed | not disclosed | not disclosed | not disclosed |
| Amedisys, Inc. | not disclosed | not disclosed | not disclosed | not disclosed |
| Astrana Health, Inc. | 193.8% | PSU 67 · RSU 33 | No | Pearl Meyer |
| Aveanna Healthcare Holdings Inc. | 200% | PSU 50 · RSU 50 | No | Aon Human Capital Solutions (division of Aon plc) |
| Chemed Corporation | 60.4% | not disclosed | Yes — 3-Year Relative TSR | Compensation Strategies, Inc. |
| Concentra Group Holdings Parent, Inc. | not disclosed | not disclosed | not disclosed | not disclosed |
| Encompass Health Corporation | 173.8% | PSU 60 · RSU 20 · Options 20 | No | Pay Governance |
| Option Care Health, Inc. | 111% | PSU 60 · RSU 40 | No | Pearl Meyer |
| PACS Group, Inc. | not disclosed | not disclosed | not disclosed | not disclosed |
| Pediatrix Medical Group, Inc. | 180% | PSU 50 · RSU 50 | No | Semler Brossy Consulting Group |
| Select Medical Holdings Corporation | 190% | RSU 100 | not disclosed | not disclosed |
| Surgery Partners, Inc. | not disclosed | PSU 60 · Restricted Stock 40 | No | Frederic W. Cook & Co., Inc. (FW Cook) |
| The Ensign Group, Inc. | not disclosed | not disclosed | not disclosed | Willis Towers Watson |
| U.S. Physical Therapy, Inc. | not disclosed | not disclosed | not disclosed | not disclosed |
Read from each company's Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company's filing does not state the item.
Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.
| # | Supports | Document | Filed | Accession | Location in document |
|---|---|---|---|---|---|
| 1 | Section 01, Howard Berger | DEF 14A | 2026-04-20 | 0001683168-26-003086 | Section “EXECUTIVE COMPENSATION TABLES” · page 35. As printed: 12,087,934. Filing ↗machine: t93 · r1 · c26 · span 428610–428620 |
| 2 | Section 01, Stephen Forthuber | DEF 14A | 2026-04-20 | 0001683168-26-003086 | Section “EXECUTIVE COMPENSATION TABLES” · page 35. As printed: 3,254,446. Filing ↗machine: r9 · c26 · span 442210–442219 |
| 3 | Section 01, Norman Hames | DEF 14A | 2026-04-20 | 0001683168-26-003086 | Section “EXECUTIVE COMPENSATION TABLES” · page 35. As printed: 3,238,056. Filing ↗machine: r13 · c26 · span 448528–448537 |
| 4 | Section 01, Mital Patel | DEF 14A | 2026-04-20 | 0001683168-26-003086 | Section “EXECUTIVE COMPENSATION TABLES” · page 35. As printed: 3,055,554. Filing ↗machine: r17 · c26 · span 454846–454855 |
| 5 | Section 01, Mark Stolper | DEF 14A | 2026-04-20 | 0001683168-26-003086 | Section “EXECUTIVE COMPENSATION TABLES” · page 35. As printed: 2,833,489. Filing ↗machine: r5 · c26 · span 434966–434975 |
| 6 | Section 03, Norman Hames PSU | DEF 14A | 2026-04-20 | 0001683168-26-003086 | Section “Summary Compensation Table” · grants of plan-based awards table. Filing ↗machine: t83 · r3 · c7 · span 386906–386912 |
| 7 | Section 03, Stephen Forthuber PSU | DEF 14A | 2026-04-20 | 0001683168-26-003086 | Section “Summary Compensation Table” · grants of plan-based awards table. Filing ↗machine: t93 · r9 · c14 · span 441570–441579 |
| 8 | Section 03, Mark Stolper PSU | DEF 14A | 2026-04-20 | 0001683168-26-003086 | Section “Summary Compensation Table” · grants of plan-based awards table. Filing ↗machine: t93 · r5 · c14 · span 434326–434335 |
| 9 | Section 03, Howard Berger PSU | DEF 14A | 2026-04-20 | 0001683168-26-003086 | Section “Summary Compensation Table” · grants of plan-based awards table. Filing ↗machine: t83 · r1 · c7 · span 385745–385752 |
| 10 | Section 03, Mital Patel PSU | DEF 14A | 2026-04-20 | 0001683168-26-003086 | Section “Summary Compensation Table” · grants of plan-based awards table. Filing ↗machine: t93 · r17 · c14 · span 454206–454215 |
| 11 | Section 07, pay ratio | DEF 14A | 2026-04-20 | 0001683168-26-003086 | Section “CEO Pay Ratio”. As printed: 263 : 1. Filing ↗machine: span 933861–933871 |
| 12 | Section 08, David L. Swartz | DEF 14A | 2026-04-20 | 0001683168-26-003086 | Section “Director Compensation”. As printed: 308,524. Filing ↗machine: t47 · r4 · c11 · span 272241–272248 |
| 13 | Section 08, Lawrence L. Levitt | DEF 14A | 2026-04-20 | 0001683168-26-003086 | Section “Director Compensation”. As printed: 273,524. Filing ↗machine: t47 · r1 · c11 · span 268799–268806 |
| 14 | Section 08, Laura P. Jacobs | DEF 14A | 2026-04-20 | 0001683168-26-003086 | Section “Director Compensation”. As printed: 268,524. Filing ↗machine: t47 · r2 · c11 · span 269949–269956 |
| 15 | Section 08, Gregory E. Spurlock | DEF 14A | 2026-04-20 | 0001683168-26-003086 | Section “Director Compensation”. As printed: 251,024. Filing ↗machine: t47 · r3 · c11 · span 271102–271109 |
| 16 | Section 08, A. Gregory Sorensen, M.D | DEF 14A | 2026-04-20 | 0001683168-26-003086 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 17 | Section 08, Howard G. Berger, M.D | DEF 14A | 2026-04-20 | 0001683168-26-003086 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 18 | Section 02, Howard Berger 2026-05-05 | Form 4 | 2026-05-06 | 0001683168-26-003541 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 19 | Section 02, Howard Berger 2026-05-05 | Form 4 | 2026-05-06 | 0001683168-26-003541 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 20 | Section 02, David L. Swartz 2026-06-02 | Form 4 | 2026-06-03 | 0001683168-26-004530 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 21 | Section 02, Lawrence L. Levitt 2026-06-02 | Form 4 | 2026-06-03 | 0001683168-26-004527 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 22 | Section 02, Laura P. Jacobs 2026-06-02 | Form 4 | 2026-06-03 | 0001683168-26-004528 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 23 | Section 02, Gregory E. Spurlock 2026-06-02 | Form 4 | 2026-06-03 | 0001683168-26-004529 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 24 | Section 02, Stephen Forthuber 2026-06-15 | Form 4 | 2026-06-16 | 0001683168-26-004874 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 25 | Section 02, Stephen Forthuber 2026-06-15 | Form 4 | 2026-06-16 | 0001683168-26-004874 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 26 | Section 02, Cornelis Wesdorp 2026-06-16 | Form 4 | 2026-06-18 | 0001683168-26-004992 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 27 | Section 02, Howard Berger 2026-06-16 | Form 4 | 2026-06-18 | 0001683168-26-004991 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 28 | Section 02, David L. Swartz 2026-06-18 | Form 4 | 2026-06-22 | 0001683168-26-005022 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 29 | Section 06, 2026 vote | Form 8-K | 2026-06-04 | 0001683168-26-004522 | Item 5.07 · say-on-pay result. As reported: 93.9% (votes for as printed: 61,158,497). Filing ↗ |
| 30 | Section 06, 2025 vote | Form 8-K | 2025-06-12 | 0001683168-25-004440 | Item 5.07 · say-on-pay result. As reported: 82.88% (votes for as printed: 50,822,611). Filing ↗ |
| 31 | Section 06, 2024 vote | Form 8-K | 2024-06-13 | 0001683168-24-004201 | Item 5.07 · say-on-pay result. As reported: 88.63% (votes for as printed: 53,924,684). Filing ↗ |
| 32 | Section 03b vehicle mix (computed) | Computed | — | computed | RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio |
| 33 | Section 09b board cost (computed) | Computed | — | computed | Cash 461,500 + equity 640,096 + all other 0 = 1,101,596, summed across the director compensation table rows.machine: formula: Σ = 1,101,596 |
| 34 | Astrana Health, Inc., Section 10b CEO total | DEF 14A | 2026-04-17 | 0001104659-26-044536 | CEO total compensation as printed in Astrana Health, Inc.'s own proxy. As printed: 14,930,231. Filing ↗machine: span 525189–525199 |
| 35 | The Ensign Group, Inc., Section 10b CEO total | DEF 14A | 2026-04-02 | 0001125376-26-000014 | CEO total compensation as printed in The Ensign Group, Inc.'s own proxy. As printed: 13,804,700. Filing ↗machine: span 521316–521326 |
| 36 | Chemed Corporation, Section 10b CEO total | DEF 14A | 2026-04-09 | 0001562762-26-000052 | CEO total compensation as printed in Chemed Corporation's own proxy. As printed: 12,904,720. Filing ↗machine: t18 · r8 · c8 · span 1091846–1091856 |
| 37 | RadNet (subject), Section 10b CEO total | DEF 14A | 2026-04-20 | 0001683168-26-003086 | CEO total compensation as printed in RadNet's own proxy. As printed: 12,087,934. Filing ↗machine: t93 · r1 · c26 · span 428610–428620 |
| 38 | Encompass Health Corporation, Section 10b CEO total | DEF 14A | 2026-04-07 | 0000785161-26-000105 | CEO total compensation as printed in Encompass Health Corporation's own proxy. As printed: 10,297,258. Filing ↗machine: r2 · c48 · span 734470–734480 |
| 39 | AdaptHealth Corp, Section 10b CEO total | DEF 14A | 2026-04-28 | 0001628280-26-027965 | CEO total compensation as printed in AdaptHealth Corp's own proxy. As printed: 10,256,240. Filing ↗machine: r2 · c48 · span 476441–476451 |
| 40 | Option Care Health, Inc., Section 10b CEO total | DEF 14A | 2026-04-08 | 0001140361-26-013825 | CEO total compensation as printed in Option Care Health, Inc.'s own proxy. As printed: 9,266,330. Filing ↗machine: r2 · c25 · span 1114074–1114083 |
| 41 | Acadia Healthcare Company, Inc., Section 10b CEO total | DEF 14A | 2026-03-25 | 0001140361-26-011130 | CEO total compensation as printed in Acadia Healthcare Company, Inc.'s own proxy. As printed: 7,909,463. Filing ↗machine: t159 · r1 · c27 · span 558066–558075 |
| 42 | Surgery Partners, Inc., Section 10b CEO total | DEF 14A | 2026-04-23 | 0001638833-26-000039 | CEO total compensation as printed in Surgery Partners, Inc.'s own proxy. As printed: 6,083,862. Filing ↗machine: r2 · c24 · span 365862–365872 |
| 43 | Aveanna Healthcare Holdings Inc., Section 10b CEO total | DEF 14A | 2026-04-17 | 0001193125-26-161632 | CEO total compensation as printed in Aveanna Healthcare Holdings Inc.'s own proxy. As printed: 4,864,165. Filing ↗machine: r3 · c31 · span 437702–437711 |
| 44 | Select Medical Holdings Corporation, Section 10b CEO total | DEF 14A | 2026-03-04 | 0001104659-26-023205 | CEO total compensation as printed in Select Medical Holdings Corporation's own proxy. As printed: 3,042,527. Filing ↗machine: r13 · c41 · span 384685–384694 |
| 45 | Pediatrix Medical Group, Inc., Section 10b CEO total | DEF 14A | 2026-03-27 | 0001193125-26-127299 | CEO total compensation as printed in Pediatrix Medical Group, Inc.'s own proxy. As printed: 2,775,881. Filing ↗machine: r22 · c24 · span 1960691–1960700 |
| 46 | Section 10a, Encompass Health Corporation reciprocity | DEF 14A | — | 0000785161-26-000105 | Encompass Health Corporation's most recent proxy was read; its disclosed peer group does not include RadNet. Filing ↗ |
| 47 | Section 10a, Aveanna Healthcare Holdings Inc. reciprocity | DEF 14A | — | 0001193125-26-161632 | Aveanna Healthcare Holdings Inc. names RadNet in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 48 | Section 10a, Acadia Healthcare Company, Inc. reciprocity | DEF 14A | — | 0001140361-26-011130 | Acadia Healthcare Company, Inc.'s most recent proxy was read; its disclosed peer group does not include RadNet. Filing ↗ |
| 49 | Section 10a, Option Care Health, Inc. reciprocity | DEF 14A | — | 0001140361-26-013825 | Option Care Health, Inc.'s most recent proxy was read; its disclosed peer group does not include RadNet. Filing ↗ |
| 50 | Section 10a, AdaptHealth Corp reciprocity | DEF 14A | — | 0001628280-26-027965 | AdaptHealth Corp names RadNet in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 51 | Section 10a, Surgery Partners, Inc. reciprocity | DEF 14A | — | 0001638833-26-000039 | Surgery Partners, Inc. names RadNet in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 52 | Section 10a, Chemed Corporation reciprocity | DEF 14A | — | 0001562762-26-000052 | Chemed Corporation names RadNet in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 53 | Section 10a, The Ensign Group, Inc. reciprocity | DEF 14A | — | 0001125376-26-000014 | The Ensign Group, Inc.'s most recent proxy was read; its disclosed peer group does not include RadNet. Filing ↗ |